Overview
Wysa is an AI-powered emotional wellbeing app that uses evidence-based CBT, DBT, and mindfulness techniques delivered via a conversational chatbot. It is used by millions globally and has partnerships with healthcare systems in the UK and India.
Wysa is an AI-powered emotional wellbeing platform that delivers clinically-validated mental health support through a conversational chatbot interface. The app leverages evidence-based therapeutic techniques including Cognitive Behavioral Therapy (CBT), Dialectical Behavior Therapy (DBT), and mindfulness practices to help users manage stress, anxiety, depression, and other mental health challenges. By combining natural language processing with therapeutic protocols, Wysa makes mental health care accessible and affordable at scale, reaching millions of users globally who might otherwise lack access to traditional therapy services.
Founded in Bangalore, India, Wysa has established itself as a significant player in the mental health technology space, securing Series B funding of $30 million to fuel expansion. The company has built strategic partnerships with healthcare systems across the UK and India, validating its clinical approach and demonstrating real-world effectiveness within institutional settings. These partnerships underscore the platform's credibility and highlight growing recognition from established healthcare providers that AI-driven mental health solutions can complement and extend traditional care delivery.
Wysa represents a critical intersection in the neurotech industry where AI technology directly addresses one of the world's most pressing health challenges: the global mental health crisis and shortage of qualified therapists. By democratizing access to evidence-based psychological interventions through technology, Wysa exemplifies how neurotechnology can scale mental health support beyond traditional clinical capacity constraints. The company's approach demonstrates that conversational AI, when grounded in rigorous therapeutic science, can serve as a meaningful tool for population-level mental health improvement and early intervention.
More in Mental Health Tech
Latest industry news
Synchron Closes $275M Series D to Accelerate Stentrode BCI Commercialization
2026-06-15 ยท Funding
MIT Researchers Demonstrate Real-Time Emotion Decoding via Non-Invasive EEG with 94% Accuracy
2026-06-13 ยท Research
Synchron Launches Stentrode Home Edition, Expanding BCI Access Beyond Clinical Settings
2026-06-11 ยท Product
Synchron Reaches 100-Patient Milestone as Stentrode BCI Moves Toward Pivotal Trial
2026-06-09 ยท Industry
Company details
Category
๐ Mental Health Tech
Location
Bangalore, India
Funding
Series B ยท $30M
Website
wysa.ioListed
2026-06-15
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages โ